Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cellular Biomedicine Group announces discontinuation of consulting business segment


Monday, 30 Jun 2014 09:05am EDT 

Cellular Biomedicine Group Inc:Announces the discontinuation of the company's consulting business segment.Consulting business is expected to be classified as discontinued operations, effective July 1.Expects to record a one-time pre-tax cash charge of about $840,000 in the second quarter 2014 resulting from severance to be paid to employees affiliated with the consulting business.